AIM
ALMR

ARK Investment Management’s Alamar Biosciences ALMR Stock Holding History

ARK Investment Management’s Portfolio ALMR Stock Details ALMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.2M Buy
+1,373,959
New +$31.1M 0.24% 70

Other funds holding ALMR

SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

ARK Investment Management's ALMR Position: Q2 2026 in Review

ARK Investment Management opened a new position in Alamar Biosciences (ALMR) in Q2 2026: 1,373,959 shares worth $37.2M. The stake represents 0.24% of the portfolio and ranks #70 among its holdings.

73 funds tracked by Wall St. Rank hold ALMR as of Q2 2026.

  • ARK Investment Management held 1,373,959 shares of Alamar Biosciences worth $37.2M as of Q2 2026.
  • Alamar Biosciences was a new ARK Investment Management position in Q2 2026.
  • Alamar Biosciences made up 0.24% of ARK Investment Management's portfolio in Q2 2026, its #70 holding.
  • 73 funds tracked by Wall St. Rank held Alamar Biosciences as of Q2 2026.

Based on ARK Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.